Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Kitts & Nevis Business Watch.
Press releases published on July 3, 2025
Lumine Group Completes the Purchase of Datafusion Systems
GlobeNewswire
·
July 3, 2025
TORONTO, July 03, 2025 (GLOBE NEWSWIRE) -- Lumine Group Inc. (“Lumine Group” or “the Company”) (TSXV: LMN), a global buy-and-hold forever acquirer of communications and media software businesses, today announced that it has completed the purchase of …
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 3, 2025
BEDFORD, Mass., July 03, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on July 1, …
Preferred Bank Announces 2025 Second Quarter Earnings Release and Conference Call
GlobeNewswire
·
July 3, 2025
LOS ANGELES, July 03, 2025 (GLOBE NEWSWIRE) -- Preferred Bank (NASDAQ: PFBC), one of the larger independent commercial banks in California, today announced plans to release its financial results for the second quarter ended June 30, 2025 before the open of …
TransAlta to Host Second Quarter 2025 Results Conference Call
GlobeNewswire
·
July 3, 2025
CALGARY, Alberta, July 03, 2025 (GLOBE NEWSWIRE) -- TransAlta Corporation (“TransAlta”) (TSX:TA)(NYSE:TAC) will release its second quarter 2025 results before markets open on Friday, August 1, 2025. A conference call and webcast to discuss the results will …
Bioma Probiotics Redefines Digestive Health in 2025 With Its Strongest Prebiotic, Probiotic, and Postbiotic Synergy Yet
GlobeNewswire
·
July 3, 2025
San Francisco, July 03, 2025 (GLOBE NEWSWIRE) -- Section 1 – Introduction The increasing visibility of the gut microbiome in health-related online searches continues to reshape public interest in non-clinical wellness solutions. In particular, consumer …
EQV Ventures Acquisition Corp. II Announces Closing of Upsized $460 Million Initial Public Offering and Partial Exercise of Over-Allotment Option
GlobeNewswire
·
July 3, 2025
PARK CITY, UTAH, July 03, 2025 (GLOBE NEWSWIRE) -- EQV Ventures Acquisition Corp. II (the “Company”), a special purpose acquisition company sponsored by an affiliate of the EQV Group, and formed for the purpose of entering into a business combination with …
PhenQ Updates 2025 Formula With Strongest OTC Appetite Suppressant Profile and Clinically Studied Craving Support Ingredients
GlobeNewswire
·
July 3, 2025
Austin, July 03, 2025 (GLOBE NEWSWIRE) -- Section 1 – Introduction As public discourse around weight management increasingly centers on metabolic wellness and lifestyle sustainability, interest in ingredient transparency and multi-pronged dietary support …
JCPal Unveils Award-Winning Range of Shortcut Keyboards for Creative Professionals
GlobeNewswire
·
July 3, 2025
Vancouver, Canada , July 03, 2025 (GLOBE NEWSWIRE) -- JCPal Technology, a global leader in the design and manufacturing of premium tech accessories, announced today the launch of Dash, an innovative range of wireless shortcut keyboards built specifically …
Contact Levi & Korsinsky by August 11, 2025 Deadline to Join Class Action Against Rocket Pharmaceuticals, Inc. (RCKT)
GlobeNewswire
·
July 3, 2025
NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi …
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Hims & Hers Health, Inc. (HIMS) Shareholders
GlobeNewswire
·
July 3, 2025
NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi …
Community Impact Coalition Commends Congressional Approval of “One Big Beautiful Bill,” Protecting Nonprofit Tax Status
GlobeNewswire
·
July 3, 2025
Washington, DC, July 03, 2025 (GLOBE NEWSWIRE) -- The Community Impact Coalition (CIC), a network of over 100 national and state nonprofits, today celebrates the final passage of the “One Big Beautiful Bill Act,” which protects critical nonprofit tax …
August 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against RDDT
GlobeNewswire
·
July 3, 2025
NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi …
Levi & Korsinsky Reminds Iovance Biotherapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 14, 2025 – IOVA
GlobeNewswire
·
July 3, 2025
NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi …
Class Action Filed Against Krispy Kreme, Inc. (DNUT) Seeking Recovery for Investors – Contact Levi & Korsinsky
GlobeNewswire
·
July 3, 2025
NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi …
Digimarc Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights – DMRC
GlobeNewswire
·
July 3, 2025
NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi …
Investors who lost money on Compass Group Diversified Holdings, LLC (CODI) should contact Levi & Korsinsky about pending Class Action - CODI
GlobeNewswire
·
July 3, 2025
NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi …
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Vestis Corporation (VSTS) Shareholders
GlobeNewswire
·
July 3, 2025
NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi …
Opus Genetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 3, 2025
RESEARCH TRIANGLE PARK, N.C., July 03, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for …
USCB Financial Holdings, Inc. To Announce Second Quarter 2025 Results
GlobeNewswire
·
July 3, 2025
MIAMI, July 03, 2025 (GLOBE NEWSWIRE) -- USCB FINANCIAL HOLDINGS, INC. (the “Company”) (NASDAQ: USCB) will report financial results for the quarter ended June 30, 2025 after the market closes on Thursday, July 24, 2025. A conference call to discuss …
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 3, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …